KZR-504 is a highly selective inhibitor of immunoproteasome low molecular mass polypeptide 2 (LMP2) , with IC 50 s of 51 nM, 4.274 μM for LMP2 and LMP7, respectively. KZR-504 is of interest for the treatment of autoimmune diseaseIn VivoEvaluating the inhibition of LMP2, and antitargets LMP7 and β5, in mouse tissues reveals that KZR-504 (compound 12) is both selective and potent in vivo with >50% target inhibition achieved at >1 mg/kg in all tissues tested except brain . MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:IC50: 51 nM (LMP2), 4.274 μM (LMP7).
Specifications and Purity: ≥98%
Molecular Formula: C21H23N3O6
Molecular Weight: 413.42
- UPC:
- 41101902
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- K650744-100mg
- CAS:
- 1629052-78-3
- Product Size:
- 100mg
akash.verma@cenmed.com
(732) 447-1115





